These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 9471233)
1. [Role of calcium antagonists in the treatment of arterial hypertension]. Velasco M; NegrÃn C Invest Clin; 1997 Nov; 38 Suppl 2():65-72. PubMed ID: 9471233 [TBL] [Abstract][Full Text] [Related]
2. Ca2+ channel subtypes and pharmacology in the kidney. Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972 [TBL] [Abstract][Full Text] [Related]
3. [Differential therapy with calcium antagonists]. Scholze JE Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111 [TBL] [Abstract][Full Text] [Related]
5. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
6. Nilvadipine: profile of a new calcium antagonist. An overview. Rosenthal J J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological basis for use of calcium antagonists in hypertension. Scriabine A; Kazda S Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846 [TBL] [Abstract][Full Text] [Related]
8. Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine. Opie LH Postgrad Med J; 1991; 67 Suppl 5():S2-8. PubMed ID: 1666430 [TBL] [Abstract][Full Text] [Related]
10. Application of calcium channel blockers in the treatment of cardiovascular diseases. Herman ZS Pol J Pharmacol; 1999; 51(2):201-6. PubMed ID: 10425650 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes. Zakhari S Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569 [TBL] [Abstract][Full Text] [Related]
12. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists. Sarsero D; Fujiwara T; Molenaar P; Angus JA Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350 [TBL] [Abstract][Full Text] [Related]
13. The actions and role of calcium entry blockers in hypertension: cardiac considerations. Sole MJ Clin Invest Med; 1989 Oct; 12(5):294-9. PubMed ID: 2689025 [TBL] [Abstract][Full Text] [Related]
14. [Calcium antagonists in the treatment of arterial hypertension. Attempt at a differential therapy]. Kiowski W Fortschr Med; 1984 Jul; 102(27-28):721-4. PubMed ID: 6479815 [TBL] [Abstract][Full Text] [Related]
15. Use of calcium channel blockers in hypertension. Conlin PR; Williams GH Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192 [TBL] [Abstract][Full Text] [Related]
16. Amlodipine: a new calcium antagonist. Clavijo GA; de Clavijo IV; Weart CW Am J Hosp Pharm; 1994 Jan; 51(1):59-68. PubMed ID: 8135260 [TBL] [Abstract][Full Text] [Related]
17. Comparative clinical pharmacology of calcium channel blockers. Kim KE Am Fam Physician; 1991 Feb; 43(2):583-8. PubMed ID: 1990741 [TBL] [Abstract][Full Text] [Related]
18. Vascular effects of calcium channel antagonists: new evidence. Richard S Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057 [TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers. Is it time to split the lump? Materson BJ Am J Hypertens; 1995 Mar; 8(3):325-9. PubMed ID: 7794584 [TBL] [Abstract][Full Text] [Related]
20. Role of calcium on excitation-contraction coupling in cardiac and vascular smooth muscle. Lucchesi BR Circulation; 1989 Dec; 80(6 Suppl):IV1-13. PubMed ID: 2557175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]